Ozempic and Wegovy maker courts Black leaders seeking Medicare's favor : Shots
Drugmaker Novo Nordisk focuses on Black lawmakers and opinion leaders to spread the message that obesity is a chronic disease — worth treating at a cost of $1,000 or more a month.
Source: npr.org
